» Articles » PMID: 28337276

MicroRNA-9 Regulates Non-small Cell Lung Cancer Cell Invasion and Migration by Targeting Eukaryotic Translation Initiation Factor 5A2

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2017 Mar 25
PMID 28337276
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) play a critical role in cancer development and progression. Bioinformatics analyses has identified eukaryotic translation initiation factor 5A2 (eIF5A2) as a target of miR-9. In this study, we attempted to determine whether miR-9 regulates non-small cell lung cancer (NSCLC) cell invasion and migration by targeting eIF5A2 We examined eIF5A2 expression using reverse transcription-quantitative PCR (RT-qPCR) and subsequently transfected A549 and NCI-H1299 NSCLC cells with a miR-9 mimic or miR-9 inhibitor to determine the migration and invasive capability of the cells via wound healing assay and Transwell invasion assay, respectively. E-cadherin and vimentin expression was detected with western blotting. The miR-9 mimic significantly reduced NSCLC cell invasive and metastatic ability, and the miR-9 inhibitor enhanced NSCLC cell migration activity, increasing the number of migrated cells. There was no significant difference between the negative control siRNA and miR-9 mimic groups after knockdown of eIF5A2; western blotting showed that miR-9 regulated E-cadherin and vimentin expression. These data show that miR-9 regulates NSCLC cell invasion and migration through regulating eIF5A2 expression. Taken together, our findings suggest that the mechanism of miR-9-regulated NSCLC cell invasion and migration may be related to epithelial-mesenchymal transition.

Citing Articles

Investigating miR-9 and miR-222 in CSF and Plasma of Neuroblastoma Patients as Metastatic and Apoptotic-Related Markers.

Bordbar F, Rigi A, Mastanabad M, Rohani F, Ghaedi E, Dhiaa S Cell Biochem Biophys. 2024; .

PMID: 39663279 DOI: 10.1007/s12013-024-01570-9.


Clinical significance of miR-9-5p in NSCLC and its relationship with smoking.

Zhang T, Duan X, Cui Y, Zhang Y, Gu M, Wang Z Front Oncol. 2024; 14:1376502.

PMID: 38628672 PMC: 11018953. DOI: 10.3389/fonc.2024.1376502.


miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients.

Sanchez-Cabrero D, Garcia-Guede A, Burdiel M, Pernia O, Colmenarejo-Fernandez J, Gutierrez L Int J Mol Sci. 2023; 24(14).

PMID: 37511221 PMC: 10380700. DOI: 10.3390/ijms241411464.


Analysis and Validation of the Prognosis ability of the M7GRelated miRNAs in Lung Adenocarcinoma.

Qiu X, Chen Y, Zhu X, Gong Z, Yu F, Zhang P Asian Pac J Cancer Prev. 2023; 24(4):1275-1287.

PMID: 37116150 PMC: 10352730. DOI: 10.31557/APJCP.2023.24.4.1275.


Long non-coding RNA LINC00511 promotes proliferation, invasion, and migration of non-small cell lung cancer cells by targeting miR-625-5p/GSPT1.

Cheng Y, Wang S, Mu X Transl Cancer Res. 2022; 10(12):5159-5173.

PMID: 35116366 PMC: 8798158. DOI: 10.21037/tcr-21-1468.


References
1.
Tang D, Dong S, Ma N, Xie D, Chen L, Fu L . Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma. Hepatology. 2010; 51(4):1255-63. DOI: 10.1002/hep.23451. View

2.
Wang X, Jiang R, Cui E, Feng W, Guo H, Gu D . N1-guanyl-1,7-diaminoheptane enhances the chemosensitivity of NSCLC cells to cetuximab through inhibition of eukaryotic translation initiation factor 5A2 activation. Eur Rev Med Pharmacol Sci. 2016; 20(7):1244-50. View

3.
He L, Zhao H, Li B, Liu Y, Liu M, Guan X . Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients. Int J Cancer. 2010; 129(1):143-50. DOI: 10.1002/ijc.25669. View

4.
Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

5.
Singh A, Greninger P, Rhodes D, Koopman L, Violette S, Bardeesy N . A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. Cancer Cell. 2009; 15(6):489-500. PMC: 2743093. DOI: 10.1016/j.ccr.2009.03.022. View